Highlights
NASDAQ: EDIT       Editas Medicine
Last Price Today's Change   Day's Range   Trading Volume
28.35   -0.62 (2.14%)  27.90 - 29.35  706,200

Overview

 
Avg Volume (4 weeks):746,255
4 Weeks Range:27.90 - 34.37
4 Weeks Price Volatility (%):
6.96%
52 Weeks Range:19.00 - 34.37
52 Weeks Price Volatility (%):
60.83%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company operates its business in a single segment of Developing and commercializing genome editing technology.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers